May 10, 2019
Teva launches generic Tarceva (erlotinib) tablets in the United States
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has launched a generic version of Tarceva®1(erlotinib) tablets, 100 and 150 mg, in the U.S.